University of Connecticut Health Center
Farmington, Connecticut, 06030, United States
NCT Number: NCT00408161
The purpose of this study is to evaluate the efficacy of prize contingency management (CM) in reducing in-patient detoxification services for chronic recidivist alcohol-dependent patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Farmington, Connecticut, 06030, United States
This study evaluates the efficacy of prize contingency management (CM) in reducing in-patient detoxification services for chronic recidivist alcohol-dependent patients. 116 alcohol-dependent patients who have received 4 or more alcohol detoxifications in a calendar year will be randomly assigned to one of two 6-month treatment conditions: standard case management treatment, or standard case management treatment plus CM. In the CM condition, patients earn the chance to win prizes by submitting negative breath samples and by complying with steps toward treatment goals, such as attending outpatient substance abuse treatment services, attending appointments with low income housing programs, or complying with outpatient psychiatric treatment. Treatment services received, alcohol and drug use, psychosocial functioning, and HIV risk behaviors will be measured pre-treatment and at months 1, 3, and 6 (post-treatment), and at follow-ups scheduled for 9, 12, and 18 months after intake.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
prize contingency management (CM) -- 6-month treatment plus standard case management treatment and follow-ups at 9, 12, and 18 months after intake
Other names: CM
6-month treatment standard case management treatment, and follow-ups scheduled at 9, 12, and 18 months after intake.
Time frame: 9, 12, and 18 months after intake
Time frame: 9, 12, and 18 months after intake
Time frame: 9, 12, and 18 months after intake
Time frame: 9, 12, and 18 months after intake
Time frame: 9, 12, and 18 months after intake
Time frame: 9, 12, and 18 months after intake
Time frame: 9, 12, and 18 months after intake
UConn Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04007042
Alcohol Dependence, Alcohol-Related Disorders
Nîmes, Gard, France
View Trial DetailsNCT04154111
Alcohol Abuse, Alcohol Dependence
Winston-Salem, North Carolina, United States
View Trial DetailsNCT03952429
Alcohol Abuse, Alcohol Dependence
Lindow, Brandenburg, Germany
View Trial DetailsNCT02438969
Alcohol Dependence, Alcohol-Related Disorders
Bethesda, Maryland, United States
View Trial Details